This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CE Pharm troubleshooting workshop reports
Share |

The CE Pharm conference, organized by CASSS, conducts an annual workshop on troubleshooting CE assays. The CE Pharm conference aims to bring together CE users from academia and industry, along with instrument vendors and regulatory agencies, in order to foster collaborative discussions and advance the application of CE. The troubleshooting workshop solicit real-life examples of difficult troubleshooting issues from the attendees. These are submitted anonymously prior to the start of the conference and presented by the organizers for discussion at the workshop. The intent is to allow attendees to identify whether other users are experiencing similar troubleshooting issues, as well as propose possible solutions that attendees can then test when they return to their labs. The discussions are summarized and compiled here in order to capture the points raised by the workshop attendees.

 

CE Pharm 2017 troubleshooting workshop report

CZE and CE-SDS the Discussion Continues

Workshop facilitators: Tim Blanc1, Cari Sänger-van de Griend2

Scribes: Nathan Lacher3, David Michels4, Zoran Sosic5

1. Eli Lilly and Company, Branchburg, NY, USA
2. Kantisto BV, Baarn, the Netherlands
3. Pfizer, Inc., Chesterfield, MO, USA
4. Genentech, a Member of the Roche Group, South San Francisco, CA, USA
5.Biogen, Cambridge, MA, USA

This publication reflects the views of the author and should not be construed to represent FDA's views or policies.

To download the full paper, click here.

 


CE Pharm 2016 troubleshooting workshop report

cIEF and materials for CZE

Workshop facilitators: Tim Blanc1, Cari Sänger-van de Griend2

Scribes: Jiann-Kae Luo3, Joel Welch4, Tara Enda5

Compilation: Jiann-Kae Luo

1. Eli Lilly and Company, Branchburg, NY, USA
2. Kantisto BV, Baarn, the Netherlands; Uppsala University, Div. of Pharmaceutical Analytical Chemistry, Uppsala, Sweden; ACROSS, University of Tasmania, Hobart, Australia
3. Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
4. Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
This publication reflects the views of the author and should not be construed to represent FDA's views or policies.
5. Eli Lilly and Company, Branchburg, NY, USA

To download the full paper, click here.

 


CE Pharm 2015 troubleshooting workshop report

Troubleshooting CE-SDS: baseline disturbances, peak

area repeatability and the presence of ghost peaks

Workshop Leaders: Cari Sänger-van de Griend1, Timothy Blanc2
Scribes: Jiann Kae Luo3, Bernd Moritz4, Joop Waterval5, Fabian Suriano6
Compilers: Jiann Kae Luo, Cari Sänger-van de Griend

1. Kantisto BV, Baarn, the Netherlands; Uppsala University, Div. of Pharmaceutical Analytical Chemistry, Uppsala, Sweden; ACROSS, University of Tasmania, Hobart, Australia
2. Eli Lilly and Company, Branchburg, NY, USA
3. Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
4. F. Hoffmann-La Roche Ltd., Basel, Switzerland
5. Merck, Sharp & Dohme, Oss, The Netherlands
6. ANALIS s.a./n.v., Suralee, Belgium 

To download the full paper, click here.

more Calendar

1/28/2019 » 1/31/2019
CMC Strategy Forum and WCBP 2019

3/12/2019 » 3/13/2019
CMC Strategy Forum Latin America 2019

3/12/2019 » 3/15/2019
AT Europe 2019

Featured Members
Brian K. Nunnally, Seqirus, a CSL CompanyFind out more about Brian in this month's Member Spotlight!

Membership Software Powered by YourMembership  ::  Legal